Up to $2.5 million in funding from NIH will be used to develop TIMING™ kits for manufacturing analytics that provide end-users with rapid, specific and predictive results to accelerate translational research and the development and manufacture of more effective cell therapies to benefit patients
/
DateMay 02 2024
HOUSTON, Texas — May 2, 2024. CellChorus®, the dynamic single-cell analysis company™, announced that the National Center for Advancing Translational Sciences (NCATS) of the National... Read More →



















